COMPAMIR
High-Purity Fact Pipeline
© 2026 COMPAMIR | Verified Intelligence
High-Purity Fact Pipeline
Victorian Health Department, Eli Lilly
Melbourne, Australia
June 19, 2026
Verified: June 20, 2026
"Victorian health authorities issued an alert regarding counterfeit weight-loss drugs labeled as 'retatrutide'. Multiple cases of acute liver failure and serious illness have been reported in patients using these unregulated substances. The drug is currently in clinical trials by Eli Lilly and is not approved for public use."